IDEX FY 2025 interest expense - net rises 45% to USD 64.4 million

Reuters
Feb 20
IDEX FY 2025 interest expense - net rises 45% to USD 64.4 million

IDEX reported FY 2025 net sales of USD 3.46 billion (+6%), including organic sales growth of 1%. Net income attributable to shareholders was USD 483.20 million (-4%) and diluted EPS was USD 6.41 (-3%); adjusted diluted EPS was USD 7.95 (+1%). Operating income was USD 699.30 million (+3%), while operating cash flow totaled USD 680.40 million (+2%) and free cash flow was USD 616.80 million (+2%), with free cash flow conversion of 103% (from 101%). IDEX returned capital through USD 248.00 million of share repurchases and USD 213.00 million of dividends, and ended the year with USD 580.00 million in cash and cash equivalents. By segment, FY 2025 net sales were USD 1.50 billion in Health & Science Technologies (+15%) with organic sales up 4%, supported by higher volumes in data center, semiconductor consumables, and space and defense, while some semiconductor OEM, industrial and automotive demand remained lower. Fluid & Metering Technologies net sales were USD 1.22 billion (-1%), with continued momentum in municipal water partially offset by weaker volumes across chemical, energy, agriculture and other industrial markets. Fire & Safety/Diversified Products net sales were USD 745.30 million (flat), as positive price was more than offset by lower volumes in Dispensing and Fire & Safety outside North America. IDEX said interest expense rose to USD 64.40 million (+45%), primarily reflecting higher debt tied to financing the Mott acquisition, and the FY 2025 effective tax rate increased to 23.7% (from 21.1%). The company also cited productivity improvements and platform optimization savings from restructuring and cost containment actions during 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEX Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000832101-26-000003), on February 19, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10